Announcement
18 Sep 2020
In September 2020, the European Union signed an Advanced Purchase Agreement (APA) with Sanofi Pasteur-GSK for acquiring doses of the company’s COVID-19 vaccine. The agreement was published in 2021.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
18 Sep 2020
Revocation date:
18 Sep 2022
End prolongation: 30 Jun 2021
EU: Commission adopts temporary export authorisation for COVID-19 vaccines
Announced: 30 Nov 2020
EU: COVID-19 Advanced Purchase Agreement with CureVac includes localisation requirement
Announced: 20 Nov 2020
EU: Localisation requirement included in the Advanced Purchase Agreement with BioNTech-Pfizer
Announced: 27 Aug 2020
EU: COVID-19 Advanced Purchase Agreement with AstraZeneca includes localisation requirement
See all
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70729
194
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7352
152
This Thread tracks harmful trade policy interventions introduced by G7 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 13 Jan 2025
25553
38
This Thread tracks harmful trade policy interventions introduced by G20 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 15 Jan 2025
54047
121